Chemopreventive effect of indole-3-carbinol on induction of preneoplastic altered hepatic foci

Nutrition and Cancer

Volumn 50, Issue 2, 2004, Pages 214-220

  Shukla, Yogeshwer ^a   Kalra, Neetu ^a   Katiyar, Sarika ^a   Siddiqui, Imtiaz A ^a   Arora, Annu ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; ADENOSINE TRIPHOSPHATASE; ALKALINE PHOSPHATASE; DIETHYLNITROSAMINE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE 6 PHOSPHATASE; GLUTATHIONE TRANSFERASE; N (2 FLUORENYL)ACETAMIDE;

ANIMAL MODEL; ARTICLE; BODY WEIGHT; CANCER INHIBITION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; LIVER CARCINOGENESIS; LIVER TUMOR; MALE; NONHUMAN; PRECANCER; RAT; STEREOLOGY;

2-ACETYLAMINOFLUORENE; ALKALINE PHOSPHATASE; ANIMALS; ANTICARCINOGENIC AGENTS; DIETHYLNITROSAMINE; GAMMA-GLUTAMYLTRANSFERASE; GLUCOSE-6-PHOSPHATASE; GLUTATHIONE TRANSFERASE; INDOLES; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PRECANCEROUS CONDITIONS; RATS; RATS, WISTAR;

ANIMALIA; BRASSICACEAE; RATTUS NORVEGICUS;

EID: 12744278306     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5002_12     Document Type: Article

References (62)

1. Kelloff GJ, Crowell JA, Steele VE, Lubet RA, and Malone WA: Progress in cancer chemoprevention: development of diet derived chemo-preventive agents. J Nutr 130, 467-471, 2000.
2. Craig W and Beck L: Phytochemicals: health protective effects. Can J Diet Pract Res 60, 78-84, 1999.
3. Fahey JW, Zhang Y, and Talalay P: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci USA 94, 10367-10372, 1999.
4. Agarwal RC and Kumar S: Prevention of chromosomal aberrations in mouse bone marrow by indole-3-carbinol. Toxicol Lett 106, 137-141, 1999.
5. Shukla Y, Srivastava B, Arora A, and Chauhan LKS: Protective effects of indole-3-carbinol on cyclophosphamide induced clastogenecity in mouse bone marrow cells. Hum Exp Toxicol 23, 245-250, 2004.
6. Chang YC, Riby J, Chang GH, Peny BC, Firestone G, et al.: Cytostatic and antiestrogenic effects of 2-(indol-3-ylmethyl)-3,3′ diindolyl-methane, a major in vivo product of dietary indole-3-carbinol. Biochem Pharmacol 58, 825-834, 1999.
7. Yuan F, Chen DZ, Liu K, Sepkovic DW, Bradlow HL, et al.: Anti-estrogenic activities of indole-3-carbinol in cervical cells: implication for prevention of cervical cancer. Anticancer Res 19, 1673-1680, 1999.
8. Exon JH, South EH, and Magnuson K: Effects of indole-3-carbinol on immune responses, aberrant crypt foci and colonic crypt cell proliferation in rats. J Toxicol Environ Health 62, 561-573, 2001.
9. Grubbs CJ, Steele VE, Casebolt T, Juliana MM, Eto I, et al.: Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res 15, 709-716, 1995.
10. Bradlow HL, Michnovicz J, Telang NT, and Osborae MP: Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12, 1571-1574, 1991.
11. Malloy VL, Bradlow HL, and Orentreich N: Interaction between a semisynthetic diet and indole-3-carbinol on mammary tumor incidence in Balb/cfC3H mice. Anticancer Res 17, 4333-4337, 1997.
12. Srivastava B and Shukla Y: Antitumor promoting activity of indole-3-carbinol in mouse skin carcinogenesis. Cancer Lett 134, 91-95, 1998.
13. Oganesian A, Hendricks JD, and Williams DE: Long-term dietary indole-3-carbinol inhibits diethylnitrosamine-initiated hepatocarcinogenesis in the infant mouse model. Cancer Lett 118, 87-94, 1997.
14. Kojima T, Tanaka T, and Mori H: Chemoprevention of spontaneous endometrial cancer in female Donrye rats by dietary indole-3-carbinol. Cancer Res 54, 1446-1449, 1997.
15. Chung FL, Morse MA, Eklind KI, and Xu Y: Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis by compounds derived from cruciferous vegetables and green tea. Ann NY Acad Sci 686, 186-201, 1993.
16. Tanaka T, Kojima T, Morishita Y, and Mori H: Inhibitory effects of the natural products indole-3-carbinol and sinigrin during initiation and promotion phases of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis. Jpn J Cancer Res 83, 835-842, 1992.
17. Guo D, Schut HAJ, Davis CD, Snyderwine EG, Bailey GS, et al.: Protection by chlorophyllin and indole-3-carbinol against 2-amino-1-methyl-6- phenylimidazo(4,5-6)pyridine (PhIP)-induced DNA adducts and colonic aberrant crypts in the F344 rat. Carcinogenesis 16, 2931-2937, 1995.
18. Bradlow HL, Sepkovic DW, Telang NT, and Osborne MP: Multifunctional aspects of the action of indole-3-carbinol as an antitumor agent. Ann NY Acad Sci 889, 204-213, 1999.
19. Katdare M, Osborne MP, and Telang NT: Inhibition of aberrant proliferation and induction of apoptosis in preneoplastic human mammary epithelial cells by natural phytochemicals. Oncol Rep 5, 311-315, 1998.
20. Frydoonfar HR, McGrath DR, and Spigelman AD: Inhibition of proliferation of a colon cancer cell line by indole-3-carbinol. Colorectal Dis 3, 205-207, 2002.
21. Bell MC, Crowley-Nowack P, Bradlow HL, Sepkovic DW, Schmidt-Grimminger D, et al.: Placebo controlled trial of indole-3-carbinol in the treatment of cervical dysplasia. Gynecologic Oncol 78, 123-129, 2001.
22. Rosen CA, Thompson JW, Woodson GE, and Bradlow HL: Preliminary results of the use of indole-3-carbinol on recurrent respiratory papillomatosis. Otolaryngology 118, 810-815, 1998.
23. Bjeldanes LF, Kim JY, Grose KR, Bartholomew JC, and Bradfield CA: Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8- tetrachlorodibenzo-p-dioxin. Proc Natl Acad Sci USA 88, 9543-9547, 1991.
24. Bradfield CA and Bjeldanes LF: Structure-activity relationships of dietary indoles: a proposed mechanism of action as modifiers of xenobiotic metabolism. J Toxicol Environ Health 21, 311-323, 1987.
25. Wortelboer HM, de Kruif CA, van Iersel AA, Falke HE, Noordhoek J, et al.: Acid reaction products of indole-3-carbinol and their effects on cytochrome P450 and phase II enzymes in rat and monkey hepatocytes. Biochem Pharmacol 43, 1439-1447, 1992.
26. Spande TF: Hydroxyindoles, indoles, alcohols and indoethiols. In Indoles, Part 3, Houlihan WJ (ed). New York: John Wiley & Sons, 1979, pp 1-355.
27. Dashwood RH, Uyetake L, Fong AT, Hendricks JD, and Bailey GS: In vivo disposition of the natural anti-carcinogen indole-3-carbinol after p.o. administration to rainbow trout. Food Chem Toxicol 27, 385-392, 1989.
28. Stresser DM, Williams DE, Griffin DA, and Bailey GS: Mechanisms of tumor modulation by indole-3-carbinol. Disposition and excretion in male Fischer 344 rats. Drug Metab Dispos 23, 965-975, 1985.
29. Leibelt DA, Hedstrom OR, Fischer KA, Pereira CB, and Williams DE: Evaluation of chronic dietary exposure to indole-3-carbinol and absorption-enhanced 3,3′-diindolylmethane in Sprague-Dawley rats. Toxicol Sci 74, 10-21, 2003.
30. Parkin DR and Malejka-Giganti D: Differences in the hepatic P450-dependent metabolism of estrogen and tamoxifen in response to treatment of rats with 3,3′-diindolylmethane and its parent compound indole-3-carbinol. Cancer Detect Prev 28, 72-79, 2004.
31. Tatematsu M, Mera Y, Ito N, Satoh K, and Sato K: Relative merits of immunohistochemical demonstration of placental A, B and C forms of glutathione-S-transferase and histochemical demonstration of γ-glutamyl transferase as markers of altered foci during liver carcinogenesis in rats. Carcinogenesis 6, 1621-1626, 1985.
32. Tatematsu M, Mera Y, Inoue T, Satoh K, Sato K, et al.: Stable phenotypic expression of glutathione-S-transferase placental type and unstable phenotypic expression of γ-glutamyl transferase in rat liver preneoplastic and neoplastic lesions. Carcinogenesis 9, 215-220, 1988.
33. Ito N, Tsuda H, Talematsu M, Inoue T, Tagawa Y, et al.: Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione-S- transferase placental from positive foci in rats - an approach for a new medium term bioassay system. Carcinogenesis 9, 387-394, 1988.
34. Ito N, Imaida K, Hasegawa R, and Tsuda H: Rapid bioassay for carcinogens and modifiers of hepatocarcinogenesis. Crit Rev Toxicol 19, 385-415, 1989.
35. Ito N, Shirai T, and Hasegawa R: Medium term bioassay for carcinogens. In Mechanism of Carcinogenesis Risk Assessment, Vainio H, Magee PN, Mc Gregor DB, and McMichael AJ (eds). Lyon, France: IARC, 1992, pp 345-380.
36. Ito N, Tamano S, and Shirai T: A medium term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci 94, 3-8, 2003.
37. Hasegawa R and Ito N: Liver medium term bioassay in rats for screening of carcinogens and modifying factors in hepatocarcinogenesis. Food Chem Toxicol 30, 979-992, 1992.
38. Pinheiro F, Faria RR, de-Camrago JLV, Spinardi-Barbisan ALT, da-Eira AF, et al.: Chemoprevention of prenoplastic liver foci development by dietary mushroom Agaricus blazei murrill in the rat. Food Chem Toxicol 41, 1543-1550, 2003.
39. Shukla Y and Arora A: Suppression of altered hepatic foci development by curcumin in Wistar rats. Nutr Cancer 45, 53-59, 2003.
40. Rutenberg AM, Kim H, Fischbein JW, Hanker JS, Wasserkrug HL, et al.: Histochemical and ultra structural demonstration of g-glutamyl transpeptidase activity. J Histochem Cytochem 17, 17-26, 1969.
41. Wiechestein M and Meisel E: Histochemistry of hepatic phosphatases at physiological pH with special reference to demonstration of bile canaliculi. Am J Clin Pathol 27, 13-23, 1957.
42. Gomori G: Histochemistry of enzymes in tissue sections. Am J Clin Pathol 16, 177-185, 1952.
43. Bradlow HL, Sepkovic DW, Telang NT, and Osborne MP: Multifunctional aspects of the action of indole-3-carbinol as an antitumor agent. Ann NY Acad Sci 889, 204-213, 1999.
44. Kim DJ, Han BS, Ahn B, Hasegawa R, Shirai T, et al.: Enhancement by indole-3-carbinol of liver and thyroid gland neoplastic development in a rat medium-term multiorgan carcinogenesis model. Carcinogenesis 18, 377-381, 1997.
45. Stoner G, Casto B, Ralston S, Roebuck B, Pereira C, et al.: Development of a multi-organ rat model for evaluating chemopreventive agents: efficacy of indole-3-carbinol. Carcinogenesis 23, 265-272, 2002.
46. Wattenberg LW and Loub WD: Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res 38, 1410-1413, 1978.
47. Newfield L, Goldsmith A, Bradlow HL, and Auborn K: Estrogen metabolism and human papillomavirus-induced tumors of the larynx: chemo-prophylaxis with indole-3-carbinol. Anticancer Res 13, 337-341, 1993.
48. Kojima T, Tanaka T, and Mori H: Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res 54, 1446-1449, 1994.
49. 1 carcinogenesis by the natural tumor modulator indole-3-carbinol: influence of dose, duration, and intermittent exposure on indole-3-carbinol promotional potency. Cancer Res 51, 2362-2365, 1991.
50. 1-initiated hepatocarcinogenesis: results from a 9000 animal tumor study. Carcinogenesis 20, 453-458, 1999.
51. Arora A and Shukla Y: Modulation of vinca-alkaloid induced P-glycoprotein expression by indole-3-carbinol. Cancer Lett 189, 167-173, 2004.
52. Arora A, Seth K, Kalra N, and Shukla Y: Modulation of P-glycoprotein mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol Toxicol Appl Pharmacol in press.
53. Zhang L: The value of placental glutathione S-transferase and gamma-glutamyl transpeptidase as markers of altered foci during hamster pouch carcinogenesis. Carcinogenesis 15, 105-109, 1994.
54. Fukushima S, Takada N, Wanibuchi H, Hori T, Min W, et al.: Suppression of chemical carcinogenesis by water-soluble organosulfur compounds. J Nutr 131, 1049-1053, 2001.
55. Singh A, Arora A, and Shukla Y: Modulation of altered hepatic foci induction by diallyl sulfide in Wistar rats. Eur J Cancer Prev 13, 263-269, 2004.
56. Kweon S, Park KA, and Choi H: Chemopreventive effect of garlic powder in diethylnitrosamine induced rat hepatocarcinogenesis. Life Sci 73, 2515-2526, 2003.
57. Hayes JD and Pulford DJ: The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30, 445-600, 1995.
58. Yusof YA, Yan KL, and Hussain SN: Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease. Anal Quant Cytol Histol 25, 332-338, 2003.
59. Wolterboer HM, van-der-Linden EC, De-Kruif CA, Noordhoe KJ, Blaauboer BJ, et al.: Effects of indole-3-carbinol on biotransformation enzymes in the rat: in vivo changes in liver and small intestinal mucosa in comparison with primary hepatocyte cultures. Food Chem Toxicol 30, 589-599, 1992.
60. Teel RW and Huynh H: Modulation by phytochemicals of cytochrome P450-linked enzyme activity. Cancer Lett 133, 135-141, 1998.
61. Chen YH and Yang D: Differential effects of vegetable-derived indoles on the induction of quinone reductase in hepatoma cells. J Nutr Sci Vitaminol 48, 477-482, 2002.
62. Arnao MB, Sanchez-Bravo J, and Acosta M: Indole-3-carbinol as a scavenger of free radicals. Biochem Mol Biol Int 34, 1125-1134, 1996.